Puranik, P. P. Et Al. 2011. Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy. 242nd National Meeting of the American-Chemical-Society (ACS) , (Colorado, United States Of America).

Puranik, P. P., Godbole, A. M., Gediya, L. K., ALAGÖZ, Z., & Njar, V. C. O., (2011). Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy . 242nd National Meeting of the American-Chemical-Society (ACS), Colorado, United States Of America

Puranik, Purushottamachar Et Al. "Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy," 242nd National Meeting of the American-Chemical-Society (ACS), Colorado, United States Of America, 2011

Puranik, Purushottamachar P. Et Al. "Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy." 242nd National Meeting of the American-Chemical-Society (ACS) , Colorado, United States Of America, 2011

Puranik, P. P. Et Al. (2011) . "Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy." 242nd National Meeting of the American-Chemical-Society (ACS) , Colorado, United States Of America.

@conferencepaper{conferencepaper, author={Purushottamachar P. Puranik Et Al. }, title={Exploitation of multitarget prostate cancer clinical candidate VN/124-1 (TOK-001) to develop a novel class of androgen receptor down regulating agents for prostate cancer therapy}, congress name={242nd National Meeting of the American-Chemical-Society (ACS)}, city={Colorado}, country={United States Of America}, year={2011}}